(Q39730430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Mehrzad Hajialiloo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Hadise Kavandi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Alireza Khabbazi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Farid Karkon Shayan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Mohammad Oliaei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

27 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

2765-2769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

Behcet's disease in Iran: analysis of 6500 cases.

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany -- current pathogenetic concepts and therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Treatment and visual prognosis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Demographic and clinical features of Behcet's disease in Azerbaijan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Validation of the revised International Criteria for Behcet's Disease (ICBD) in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Behçet's disease: ocular effects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Prevalence of Behcet's disease in Iran: a WHO-ILAR COPCORD stage I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3318-6

Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

21 January 2018

1 reference

12 December 2020

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

1 reference

12 December 2020

Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease

1 reference

12 December 2020

Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis

1 reference

12 December 2020

Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease

1 reference

12 December 2020

Interferon alpha for ocular Behçet's disease

1 reference

12 December 2020

Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease

1 reference

12 December 2020

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

12 December 2020

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease

1 reference

12 December 2020

The rate of visual loss in Behçet's disease

1 reference

12 December 2020

Clinical manifestations of Behçet's disease: an analysis of 2147 patients

1 reference

12 December 2020

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease

1 reference

12 December 2020

Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease

1 reference

12 December 2020

10.1007/S10067-016-3318-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27234230%20AND%20SRC:MED&resulttype=core&format=json

release_e7q2rumminchzl2djwya7eot7u

3 April 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e7q2rumminchzl2djwya7eot7u

24 November 2022

mapped directly with Wikidata item

1 reference